Most Read Articles
Jairia Dela Cruz, 05 Oct 2020
Drinking more than two cups of coffee per day may just be the intervention that prevents hundreds of thousands of liver disease‐related deaths globally, a study reports.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

Stephen Padilla, Yesterday
Use of systemic corticosteroids does not reduce in-hospital mortality for patients with severe or critical coronavirus disease (COVID-19), which is in stark contrast to that observed in the RECOVERY clinical trial, according to a study in Wuhan, China.

Valvular heart disease in Asia: Outcomes remain poor

Audrey Abella
18 Nov 2019
Dr Ding Zee Pin

Several Asian studies evaluating different types of valvular heart disease (VHD) reflected poor clinical outcomes, according to a presentation at ESC Asia 2019.

In the epidemiological OxValve Survive study (n=4,009), participants with moderate-to-severe VHD were found to have a two-fold reduction in survival. “This indicates that patients with even moderate VHD does not have a benign outcome,” stressed Dr Ding Zee Pin from the National Heart Centre Singapore. “[This] warrants further research … to understand the natural history of VHD and to identify those with progressive disease and when to intervene.”

A Japanese study on 182 individuals with primary moderate mitral regurgitation (MR) showed that those with moderate MR had a worse prognosis than patients who had mild or no MR (p<0.0001). “The predictor of poor outcome is paroxysmal atrial fibrillation,” said Ding. [ESC 2019, abstract P924]

Similar results were reflected in a collaborative study between the National Heart Centre Singapore and the University of London which evaluated moderate aortic stenosis (n=522; mean age 71 years, 54 percent male). Participants with more advanced disease had a poorer outcome than those without any extravalvular involvement. [ESC 2019, abstract P5582]

Among patients with infective endocarditis, mortality continues to rise despite contemporary management. “A review of recent literature … from Asia continuously shows that … the risk is higher among patients with nosocomial infection, those with large [medically treated] vegetations, and those who have undergone haemodialysis,” said Ding.

 

Does size matter?

A comparison of aortic annulus dimensions between Japanese and European participants showed the former to have a smaller and more eccentric aortic annulus than the latter. [AsiaIntervention 2016;2:49-56] In a Singaporean cohort, the iliofemoral vessel diameter is apparently smaller. [Int J Cardiol 2013;167:1373-1379] “[These findings suggest that] the smaller Asian size poses some challenge to [TAVI*],” said Ding.

In a Japanese TAVI registry comparing participants with and without a small annulus, those with a small annulus had a smaller indexed effective orifice area (1.10 vs 1.16 cm2), a higher mean pressure gradient (10.0 vs 8.5 mm Hg), and a lower frequency of moderate paravalvular leak (17.3 percent vs 24.4 percent; p<0.001 for all), noted Ding. Nonetheless, both arms had comparable 30-day mortality and stroke rates, suggesting that a small annulus did not influence short-term clinical outcomes. [ESC 2019; abstract P1788]

 

Help at your fingertips

A handheld echo scan may provide an opportunity for VHD screening and detection. In a rheumatic heart disease (RHD) screening in Borneo, Malaysia wherein 211 schoolchildren (mean age 10 years) participated, the device identified borderline RHD in 36 percent of the participants. “[This is] a significantly high incidence of borderline RHD among this cohort, suggesting that RHD continues to be prevalent in East Malaysia,” said Ding.

Despite the favourable short- and midterm mortality rates (1–3 percent [30 days] and 8–10 percent [1 year], respectively) observed in other larger Asian TAVI registries, [Circulation 2017;135:2013-2024; JACC Cardiovasc Interv 2016;9:926-933; Korean Circ J 2018;48:382-394] longer term outcomes from these registries are warranted to elucidate the long-term survival outcomes of VHD in Asia, said Ding.

 

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 05 Oct 2020
Drinking more than two cups of coffee per day may just be the intervention that prevents hundreds of thousands of liver disease‐related deaths globally, a study reports.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

Stephen Padilla, Yesterday
Use of systemic corticosteroids does not reduce in-hospital mortality for patients with severe or critical coronavirus disease (COVID-19), which is in stark contrast to that observed in the RECOVERY clinical trial, according to a study in Wuhan, China.